April 17, 2012
Ajinomoto Pharmaceuticals and Taiho Pharmaceutical announced on April 16 that the two companies have agreed to terminate Taiho’s distributorship for Ajinomoto Pharmaceuticals’s antitumor agent Lentinan IV Infusion 1 mg “Ajinomoto” (lentinan) at the end of June due to the expiry...read more